<DOC>
	<DOCNO>NCT01275755</DOCNO>
	<brief_summary>Morphine relate opioid analgesic know slow gastrointestinal ( GI ) motility reduce intestinal secretion bind μ opioid receptor ( MORs ) within GI tract . The common symptom associated effect opioids constipation nausea and/or vomit . Moreover , constipation common distress side effect long-term opioid therapy . The primary objective study compare ADL5945 daily , MOR antagonist , placebo treatment opioid-induced constipation ( OIC ) adult take long-term opioid therapy chronic noncancer pain .</brief_summary>
	<brief_title>Evaluation Efficacy Safety ADL5945 Once Daily Treatment Opioid-induced Constipation Adults Taking Opioid Therapy Chronic Noncancer Pain</brief_title>
	<detailed_description />
	<mesh_term>Constipation</mesh_term>
	<mesh_term>Analgesics , Opioid</mesh_term>
	<criteria>Key Inclusion Criteria man woman age 18 75 year , inclusive , time screen body weight ≥45 kilogram ( kg ) body mass index ( BMI ) ≤40 kilogram per square meter ( kg/m^2 ) take stable daily dose opioids ≥30milligrams ( mg ) morphineequivalent total daily dose chronic noncancer pain ≥30 day screen opioidinduced constipation ( OIC ) history . Additionally , base data collect 1week screening period , participant must &lt; 3 spontaneous bowel movement ( SBMs ) per week experience ≥1 bowel movement ( BM ) symptom ( , strain pas stool , lumpy hard stool small pellet , sense incomplete evacuation pass stool ) ≥25 % total BMs willing discontinue use laxatives stool softener study period except allow protocol Key Exclusion Criteria pregnant , lactate , plan become pregnant study aspartate aminotransferase ( AST ) , alanine aminotransferase ( ALT ) , blood urea nitrogen , serum creatinine result ≥2 time upper limit normal recent history myocardial infarction ( MI ) unstable angina active malignancy type take opioids primarily fibromyalgia take methadone maintenance medication ( participant take methadone pain may enrol ) take intrathecal opioids management pain take tramadol , tapentadol , mixed agonist/antagonist opioid analgesic sole opioid analgesia take μopioid receptor ( MOR ) antagonist , include opioids combination naloxone , naltrexone , methylnaltrexone bromide take medical marijuana gastrointestinal ( GI ) pelvic disorder know affect bowel transit , produce GI obstruction , contribute bowel dysfunction take antispasmodic , antidiarrheal , prokinetics within 7 day start screen week take nonopioid medication know cause constipation take antidiarrheal incidence history intermittent diarrhea loose stool unwilling abstain grapefruit grapefruitcontaining product history alcoholism illicit drug dependence abuse within 5 year screen positive result urine drug screen ( exclude opioids ) indicate illicit drug use</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>January 2016</verification_date>
	<keyword>opioid therapy</keyword>
	<keyword>constipation</keyword>
	<keyword>chronic noncancer pain</keyword>
	<keyword>mu opioid receptor antagonist</keyword>
	<keyword>ADL5945</keyword>
	<keyword>Opioid Induced Constipation</keyword>
</DOC>